Skip to content
Search

Latest Stories

NHS 24 email prescriptions all set to hit pharmacies

Community pharmacies in Scotland will soon start to receive remote prescriptions from NHS 24 clinicians through email containing clinical assessment summary.

The pharmacists will receive the emails from noreply@nhs24.scot.nhs.ukand it has been adviced to add the email id to their address book to ensure the delivery of the emails from clinicians.


Prior to the launch of the new service, each pharmacy will receive an email from NHS24 (NHS24APS@nhs24.scot.nhs.uk) with a read receipt request to confirm the service has the correct email address for the pharmacy.

A follow up email will be sent a week after the initial email to all pharmacies that have not sent back a read receipt.

Dr John McAnaw, NHS 24 Head of Pharmacy said: “This approach will ensure the community pharmacist receives all relevant clinical information/context around an NHS 24 remote prescription request, and help reduce the risk of transcription errors.

“In all cases, NHS 24 prescribers will still comply with the Human Medicines Regulations 2012, ensuring the original prescription is received by the community pharmacy within 72 hours.”

NHS 24 has witnessed an increase in the number of times an NHS 24 prescriber has remotely prescribed a medicine for a member of the public calling the 111 Service.

Until now, these prescriptions have been telephoned-in to the caller’s preferred community pharmacy, without any written confirmation of the prescription being received by the pharmacist until the prescription arrives within 72 hours.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less